Literature DB >> 19628667

Urinary NGAL marks cystic disease in HIV-associated nephropathy.

Neal Paragas1, Thomas L Nickolas, Christina Wyatt, Catherine S Forster, Meghan Sise, Susan Morgello, Bernd Jagla, Charles Buchen, Peter Stella, Simone Sanna-Cherchi, Maria Luisa Carnevali, Silvia Mattei, Achiropita Bovino, Lucia Argentiero, Andrea Magnano, Prasad Devarajan, Kai M Schmidt-Ott, Landino Allegri, Paul Klotman, Vivette D'Agati, Ali G Gharavi, Jonathan Barasch.   

Abstract

Nephrosis and a rapid decline in kidney function characterize HIV-associated nephropathy (HIVAN). Histologically, HIVAN is a collapsing focal segmental glomerulosclerosis with prominent tubular damage. We explored the expression of neutrophil gelatinase-associated lipocalin (NGAL), a marker of tubular injury, to determine whether this protein has the potential to aid in the noninvasive diagnosis of HIVAN. We found that expression of urinary NGAL was much higher in patients with biopsy-proven HIVAN than in HIV-positive and HIV-negative patients with other forms of chronic kidney disease. In the HIV-transgenic mouse model of HIVAN, NGAL mRNA was abundant in dilated, microcystic segments of the nephron. In contrast, urinary NGAL did not correlate with proteinuria in human or in mouse models. These data show that marked upregulation of NGAL accompanies HIVAN and support further study of uNGAL levels in large cohorts to aid in the noninvasive diagnosis of HIVAN and screen for HIVAN-related tubular damage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19628667      PMCID: PMC2723987          DOI: 10.1681/ASN.2009010065

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  29 in total

1.  Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients.

Authors:  V Shahinian; S Rajaraman; M Borucki; J Grady; W M Hollander; T S Ahuja
Journal:  Am J Kidney Dis       Date:  2000-05       Impact factor: 8.860

Review 2.  HIV-associated nephropathy: Epidemiology, pathogenesis, and treatment.

Authors:  Elizabeth S Herman; Paul E Klotman
Journal:  Semin Nephrol       Date:  2003-03       Impact factor: 5.299

3.  An iron delivery pathway mediated by a lipocalin.

Authors:  Jun Yang; David Goetz; Jau Yi Li; Wenge Wang; Kiyoshi Mori; Daria Setlik; Tonggong Du; Hediye Erdjument-Bromage; Paul Tempst; Roland Strong; Jonathan Barasch
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

4.  Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury.

Authors:  Jaya Mishra; Qing Ma; Anne Prada; Mark Mitsnefes; Kamyar Zahedi; Jun Yang; Jonathan Barasch; Prasad Devarajan
Journal:  J Am Soc Nephrol       Date:  2003-10       Impact factor: 10.121

5.  Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes.

Authors:  J B Kopp; M E Klotman; S H Adler; L A Bruggeman; P Dickie; N J Marinos; M Eckhaus; J L Bryant; A L Notkins; P E Klotman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

6.  The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection.

Authors:  Lynda Anne Szczech; Samir K Gupta; Ramez Habash; Antonio Guasch; Robert Kalayjian; Richard Appel; Timothy A Fields; Laura P Svetkey; Katherine H Flanagan; Paul E Klotman; Jonathan A Winston
Journal:  Kidney Int       Date:  2004-09       Impact factor: 10.612

7.  Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome.

Authors:  T K Rao; E J Filippone; A D Nicastri; S H Landesman; E Frank; C K Chen; E A Friedman
Journal:  N Engl J Med       Date:  1984-03-15       Impact factor: 91.245

8.  The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy.

Authors:  Christina M Wyatt; Susan Morgello; Rebecca Katz-Malamed; Catherine Wei; Mary E Klotman; Paul E Klotman; Vivette D D'Agati
Journal:  Kidney Int       Date:  2008-12-03       Impact factor: 10.612

9.  A novel HIV-1 transgenic rat model of childhood HIV-1-associated nephropathy.

Authors:  Patricio E Ray; Xue-Hui Liu; Louis R Robinson; William Reid; Lian Xu; Jennie W Owens; Odell D Jones; Frank Denaro; Harry G Davis; Joseph L Bryant
Journal:  Kidney Int       Date:  2003-06       Impact factor: 10.612

10.  Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study.

Authors:  Gregory M Lucas; Joseph A Eustace; Stephen Sozio; Evelyn K Mentari; Kofi A Appiah; Richard D Moore
Journal:  AIDS       Date:  2004-02-20       Impact factor: 4.177

View more
  25 in total

1.  Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.

Authors:  Amandine Viau; Khalil El Karoui; Denise Laouari; Martine Burtin; Clément Nguyen; Kiyoshi Mori; Evangéline Pillebout; Thorsten Berger; Tak Wah Mak; Bertrand Knebelmann; Gérard Friedlander; Jonathan Barasch; Fabiola Terzi
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

2.  Advances in our understanding of the pathogenesis of HIV-1 associated nephropathy in children.

Authors:  Patricio E Ray; Chien-An A Hu
Journal:  Future Virol       Date:  2011-07       Impact factor: 1.831

3.  Role of circulating fibroblast growth factor-2 in lipopolysaccharide-induced acute kidney injury in mice.

Authors:  Parnell C Mattison; Angel A Soler-García; Jharna R Das; Marina Jerebtsova; Sofia Perazzo; Pingtao Tang; Patricio E Ray
Journal:  Pediatr Nephrol       Date:  2011-09-30       Impact factor: 3.714

Review 4.  NGAL-Siderocalin in kidney disease.

Authors:  Neal Paragas; Andong Qiu; Maria Hollmen; Thomas L Nickolas; Prasad Devarajan; Jonathan Barasch
Journal:  Biochim Biophys Acta       Date:  2012-06-19

Review 5.  The use of targeted biomarkers for chronic kidney disease.

Authors:  Prasad Devarajan
Journal:  Adv Chronic Kidney Dis       Date:  2010-11       Impact factor: 3.620

Review 6.  How to manage HIV-infected patients with chronic kidney disease in the HAART era.

Authors:  Minoru Ando; Ken Tsuchiya; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2012-06       Impact factor: 2.801

Review 7.  The molecular pathogenesis of HIV-1 associated nephropathy: recent advances.

Authors:  Natalia Papeta; Roel Sterken; Krzysztof Kiryluk; Robert Kalyesubula; Ali G Gharavi
Journal:  J Mol Med (Berl)       Date:  2011-01-11       Impact factor: 4.599

8.  Urinary NGAL is a useful clinical biomarker of HIV-associated nephropathy.

Authors:  David A Sola-Del Valle; Sumit Mohan; Jen-Tse Cheng; Neal A Paragas; Meghan E Sise; Vivette D D'Agati; Jonathan Barasch
Journal:  Nephrol Dial Transplant       Date:  2011-05-09       Impact factor: 5.992

Review 9.  Urinary biomarkers of kidney diseases in HIV-infected children.

Authors:  Sofia Perazzo; Ángel A Soler-García; Yetrib Hathout; Jharna R Das; Patricio E Ray
Journal:  Proteomics Clin Appl       Date:  2015-06       Impact factor: 3.494

10.  PROGRESSION OF CHRONIC KIDNEY DISEASE AFTER ACUTE KIDNEY INJURY.

Authors:  Prasad Devarajan; John Lynn Jefferies
Journal:  Prog Pediatr Cardiol       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.